[1]
S, K.C., N, S., Akbar, S., R, K. and S, A. 2026. PHYSICIAN-REPORTED EXPERIENCE WITH DAPAGLIFLOZIN IN TYPE 2 DIABETES: EVIDENCE FROM SOUTHERN INDIA. International Journal of Life Science and Pharma Research. 16, 1 (Mar. 2026), 28–33. DOI:https://doi.org/10.22376/ijlpr.v16i1.2027.